VGI Health Technology Limited (NSX:VTL) recently signed a manufacturing and supply agreement with a US manufacturer, Altipure LLC, for finished nutraceutical products for sale and clinical study drugs for our clinical studies.
Further to Azure Health Technology Limited's (NSX:VTL) announcement on 16 March 2021 that the first manufacturing run for our finished nutraceutical products has been completed.
Azure Health Technology Limited (NSX:VTL) trading as VGI Health Technology is pleased to announce that Pitt Street Research has issued an Initiation Report.
Azure Health Technology Limited trading as VGI Health Technology (NSX:VTL) is pleased to announce that an additional current Good Manufacturing Practice (cGMP) manufacturer has been appointed in the US.
Asian Activities Report for October 11, 2011 includes: Allied Healthcare Group (ASX:AHZ) says today that its investee company Coridon Pty Ltd has successfully completed pre-clinical efficacy testing of its prototype Herpes Simplex Virus 2 vaccine with outstanding results; Universal Biosensors, Inc. (ASX:UBI) has commenced a new research and development project for Cilag GmbH International to determine the feasibility of an innovative blood glucose product to be used in the field of diabetes; Kalgoorlie Mining Company Limited (ASX:KMC) reports that recent drilling of the East Lode at the Bullant gold mine has intersected a spectacular high grade gold zone; Midas Resources Limited (ASX:MDS) will commence aircore drilling on a gold target south of the Intrepid Prospect at the Company's Lake Carey Project in Western Australia.
Asian Activities Report for September 30, 2011 includes: Neon Energy Limited (ASX:NEN) says today that the recently drilled Lombardi 19-27H development well in the North San Ardo oil field, onshore California, has been brought onstream; India Resources Limited (ASX:IRL) has signed a A$249M coal operations contract with Prism Cement Limited (BOM:500338) to develop and operate the first phase of Prism's Sial Ghoghri coal mine; Guildford Coal Limited (ASX:GUF) has upgraded its Exploration Targets at its Mongolian coal projects to 30Mt to 1.380Bt; Tissue Therapies Limited (ASX:TIS) will start the sales of VitroGro(R) for the treatment of chronic wounds in the UK and Europe during the second quarter of 2012; Biotron Limited (ASX:BIT) has commenced a human trial of its lead HIV drug candidate, BIT225; Circadian Technologies Limited (ASX:CIR) has submitted an investigational new drug application to the FDA to initiate clinical studies of VGX-100.
Asian Activities Report for September 28, 2011 includes: Fletcher Building Limited (ASX:FBU) said today that Iplex Pipelines has been awarded a A$120 million contract for the supply of polyethylene pipe; Integra Mining Limited (ASX:IGR) reported aircore drilling results from reconnaissance drilling in the Mt Monger area; African Iron Limited (ASX:AKI) provides an update on drilling activities at its 92%-owned Mayoko iron ore project in the Republic of Congo; Alchemia Limited (ASX:ACL) said today that its leading cancer product HA-Irinotecan has received very promising trial results; Tata Communications (BOM:500483) has become one of the few global carriers to extend its Global IP/VPN service offerings into Pakistan.
